Neuroendocrine Tumors (NETs) are a rare and complex group of cancers that arise from neuroendocrine cells—specialized cells that possess characteristics of both nerve cells and hormone-producing endocrine cells. These tumors can develop in multiple organs, including the gastrointestinal tract, pancreas, lungs, and other sites.
Because NETs often grow slowly and may produce hormones, their diagnosis and management require specialized expertise, advanced imaging, careful pathological evaluation, and individualized treatment planning.
Dr. Lovedeep Singh Chauhan , Consultant Surgical Oncologist at Max Super Speciality Hospital, provides comprehensive, evidence-based care for patients diagnosed with Neuroendocrine Tumors. His approach integrates accurate diagnosis, advanced minimally invasive surgery, multidisciplinary coordination, and long-term follow-up.
Neuroendocrine cells are found throughout the body and are responsible for producing hormones that regulate vital functions such as digestion, metabolism, and breathing. When these cells grow abnormally, they form neuroendocrine tumors.
NETs may be:
The biological behavior of NETs varies significantly, making individualized evaluation essential.
Neuroendocrine tumors (NETs) are classified based on their primary site and biological behavior. Different types require specialized management approaches.
These are the most common NETs and can arise in:
Small bowel NETs are particularly known for causing carcinoid syndrome in advanced cases.
Pancreatic NETs originate from hormone-producing cells within the pancreas and may include:
These tumors require highly specialized surgical planning due to proximity to major blood vessels.
Lung NETs include:
Thoracic surgical expertise is often required in these cases.
Symptoms of Neuroendocrine Tumors (NETs) vary depending on tumor location and hormonal activity. Some tumors may remain silent for years, while others produce hormone-related syndromes.
Many NETs are incidentally detected during imaging for unrelated conditions.
Most neuroendocrine tumors occur sporadically without a clear cause. However, certain inherited syndromes increase risk:
Family history and genetic counseling may be recommended in select cases.
Accurate diagnosis requires a multi-step approach.
Definitive diagnosis requires tissue biopsy. Pathologists evaluate:
Grading plays a crucial role in determining prognosis and treatment.
Staging of Neuroendocrine Tumors is an important step in determining the extent of the disease and planning the most appropriate treatment strategy.
Staging is based on:
The stage determines whether surgery alone is sufficient or systemic therapy is required.
Management of NETs is individualized. Treatment depends on:
For localized and resectable NETs, surgery offers the best chance for cure. Dr. Lovedeep Singh Chauhan has specialized training in complex gastrointestinal and hepatopancreatobiliary (HPB) oncology surgeries.
Whenever feasible, advanced techniques are utilized to ensure precision and safety:
Even when complete cure is not possible, effective long-term disease control is achievable.
Treatment options include:
Treatment is carefully coordinated with medical oncology specialists.
The liver is the most common site of spread.
Management strategies may include:
Aggressive but carefully selected intervention can significantly improve survival and quality of life.
Neuroendocrine tumors require prolonged follow-up because they may recur even years after treatment.
Follow-up typically includes:
A structured follow-up protocol ensures early detection of recurrence.
Patients benefit from:
MCh Surgical Oncology from Tata Memorial Hospital with extensive experience in gastrointestinal and pancreatic cancer surgery.
Close coordination with radiologists, pathologists, medical oncologists, and critical care teams.
Each case is evaluated individually to determine:
All consultations and procedures are performed at:
Max Super Speciality Hospital
The hospital provides:
Your consultation will include:
Transparent communication and patient education are central to care.
Prognosis depends on:
Low-grade localized NETs often have excellent long-term outcomes when treated appropriately.
High-grade neuroendocrine carcinomas require aggressive multimodal therapy.